Zoltán Pető
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zoltán Pető has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
A. Molnar
Dept. of Anaesthesiology and Intensive Care, University of Szeged, Szeged, Hungary
1 shared publication- Csaba Vágvölgyi
Department of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged
1 shared publication E. Csullog
Dept. of Anaesthesiology and Intensive Care, University of Szeged, Szeged, Hungary
1 shared publicationE. Hajdu
Institute of Clinical Microbiology, University of Szeged, Szeged, Hungary
1 shared publication- Edit Urbán
Institute of Clinical Microbiology, University of Szeged, Szeged, Hungary
1 shared publication - Ferenc Somogyvari
Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Dóm tér 10, Szeged H-6720, Hungary
1 shared publication
Latest Publications
- Open Access
- 1 January 2013
- Published by Springer Nature in BMC Microbiology
- Vol. 13 (1) , 300
A novel, multiplex, real-time PCR–based approach for the detection of the commonly occurring pathogenic fungi and bacteria
Polymerase chain reaction (PCR)-based techniques are widely used to identify fungal and bacterial infections. There have been numerous reports of different, new, real-time PCR-based pathogen identification methods although the clinical practicability of such techniques is not yet fully clarified.
- 1 January 2013
- Published by Springer Nature in BMC Microbiology
- Vol. 13 (1) , 300
Open AccessA novel, multiplex, real-time PCR–based approach for the detection of the commonly occurring pathogenic fungi and bacteria
Polymerase chain reaction (PCR)-based techniques are widely used to identify fungal and bacterial infections. There have been numerous reports of different, new, real-time PCR-based pathogen identification methods although the clinical practicability of such techniques is not yet fully clarified.
- 13 November 2008
- Published by Springer Nature in Infection
- Vol. 36 (6) , 560-564
Results of a Local Antibiotic Management Program on Antibiotic Use in a Tertiary Intensive Care Unit in Hungary
Background: Massive antibiotic use in intensive care units (ICU) is associated with increased microbial resistance. Therefore avoiding unneccesary antibiotic usage is essential. To achieve a more considered antibiotic prescribing practice, a new antibiotic policy was implemented at our ICU. In this paper, we evaluated the impact of this intervention, and described the aetiology and incidence of blood stream infections and selected antibiotic-resistant pathogens. Materials and Methods: In November 2002, a local antibiotic management program (LAMP) was implemented. This included a new infectious diseases specialist consultation service and restricted authorisation to prescribe antibiotics. The effect on ward-level antibiotic use was examined by segmented regression analysis. Patient, ICU and microbiology data were also recorded and compared before and after policy implementation. Results: The patient populations and the subsequent mortality rate were comparable before and after the implementation of the policy. Total antibiotic consumption was markedly reduced from 162.9 to 101.3 defined daily dose (DDD) per 100 patients, and per day (DDD per 100 patient-days). This was mainly accounted for a reduction in the use of quinolones, aminoglycosides, glycopeptides, metronidazol, carbepenems and third generation cephalosporins. Conclusion: This study has confirmed that establishing a targeted LAMP, based on close co-operation between intensive care physicians and infectious disease specialists together with a restricted prescribing authority, can reduce the use of antibiotics.
- 13 November 2008
- Published by Springer Nature in Infection
- Vol. 36 (6) , 560-564
Results of a Local Antibiotic Management Program on Antibiotic Use in a Tertiary Intensive Care Unit in Hungary
Background: Massive antibiotic use in intensive care units (ICU) is associated with increased microbial resistance. Therefore avoiding unneccesary antibiotic usage is essential. To achieve a more considered antibiotic prescribing practice, a new antibiotic policy was implemented at our ICU. In this paper, we evaluated the impact of this intervention, and described the aetiology and incidence of blood stream infections and selected antibiotic-resistant pathogens. Materials and Methods: In November 2002, a local antibiotic management program (LAMP) was implemented. This included a new infectious diseases specialist consultation service and restricted authorisation to prescribe antibiotics. The effect on ward-level antibiotic use was examined by segmented regression analysis. Patient, ICU and microbiology data were also recorded and compared before and after policy implementation. Results: The patient populations and the subsequent mortality rate were comparable before and after the implementation of the policy. Total antibiotic consumption was markedly reduced from 162.9 to 101.3 defined daily dose (DDD) per 100 patients, and per day (DDD per 100 patient-days). This was mainly accounted for a reduction in the use of quinolones, aminoglycosides, glycopeptides, metronidazol, carbepenems and third generation cephalosporins. Conclusion: This study has confirmed that establishing a targeted LAMP, based on close co-operation between intensive care physicians and infectious disease specialists together with a restricted prescribing authority, can reduce the use of antibiotics.